Helsinn and Zealand announce the advance of elsiglutide into Phase IIB development for the prevention of chemotherapyinduced diarrhea

6 February 2015

Helsinn Group grants stendhal international exclusive rights to the distribution and marketing of Netupitant-Palonosetron (nepa) in multiple countries of Latin America

3 February 2015

Helsinn awards scholarships for advanced synthesis

1 December 2014

Cerbios-Pharma SA and Lipidor AB strengthen partnership

18 August 2014

Helsinn Group and Gen Ilaç establish a collaboration for anamorelin in Turkey

12 July 2014

Helsinn to provide an independent educational grant support for a satellite symposium on Comprehensive Cancer Care

12 July 2014

Helsinn Therapeutics (U.S.), inc. Strengthens its board of directors

11 July 2014

Cerbios Pharma successfully passes a general FDA GMP inspection

29 April 2014

Cerbios-Pharma: Construction has started on the new R&D Laboratories Building

29 April 2014

Helsinn promotes the use of mobile technology in cancer supportive care through mobile health

10 April 2014